Novo Nordisk (NVO) is slated to report second-quarter 2024 results on Aug 7, before the opening bell. The Zacks Consensus Estimate for quarterly revenues in the to-be-reported quarter is pegged at 9.91billion,whilethesameforearningsispinnedat76centspershare.Inthepast30days,theestimatesforNovoNordisk’s2024earningspershare(EPS)deterioratedfrom3.41 to 3.38.Duringthesametimeframe,theforecastforthecompany’s2025EPShasimprovedfrom4.30 to $4.35.Image Source: Zacks I ...